Mots-clés
 > MYOBASE > MOTS OUTILS > âge > enfance > adolescent
adolescent
Commentaire :
L'adolescence est la période commençant avec l'apparition des caractères sexuels secondaires et s'achevant avec la fin de la croissance somatique. L'usage courant du terme d'adolescent désigne un individu entre 13 et 18 ans. (D'après le MeSH ; 04/07/2005)
Synonyme(s)adolescence ;teen-ager ;teenager ;teens teenagersVoir aussi |
Mettre toutes les notices dans le panier Faire une suggestion Ajouter un critère de rechercheEtendre la recherche sur niveau(x) vers le bas
Cerebrospinal fluid proteomic profiling in nusinersen-treated patients with spinal muscular atrophy
Kessler T, Latzer P, Schmid D, et al.
Journal of neurochemistry, 2020
Juvenile Dermatomyositis and Development of Malignancy: 2 Case Reports and a Literature Review
Cannon L, Dvergsten J, Stingl C
The Journal of rheumatology, 2020
Late-onset riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency (MADD): case reports and epidemiology of ETFDH gene mutations
Chen W, Zhang Y, Ni Y, et al.
BMC neurology, 2019, 19, 1, p 330
Practical approach to respiratory emergencies in neurological diseases
Racca F, Vianello A, Mongini T, et al.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2019
Hormonal and metabolic gender differences in a cohort of myotonic dystrophy type 1 subjects: a retrospective, case-control study
Spaziani M, Semeraro A, Bucci E, et al.
Journal of endocrinological investigation, 2019
Nusinersen for older patients with spinal muscular atrophy: A real-world clinical setting experience
Veerapandiyan A, Eichinger K, Guntrum D, et al.
Muscle & Nerve, 2019
Management of the dentoalveolar effects of tongue hypertrophy in patients with Duchenne muscular dystrophy: A pilot study
Antonarakis GS, Morel C, Kiliaridis S
Neuromuscular disorders : NMD, 2019, 22, 23
Neurofilament light chain in serum of adolescent and adult SMA patients under treatment with nusinersen
Wurster CD, Steinacker P, Gunther R, et al.
Journal of neurology, 2019
Exercise Combined with Electrotherapy Enhances Motor Function in an Adolescent with Spinal Muscular Atrophy Type III
Gobbo M, Lazzarini S, Vacchi L, et al.
Case reports in neurological medicine, 2019
Motor learning from virtual reality to natural environments in individuals with Duchenne muscular dystrophy
Quadrado VH, Silva TDD, Favero FM, et al.
Disability and rehabilitation. Assistive technology, 2019, 14, 1, p 12
Efficacy, safety profile, and immunogenicity of alglucosidase alfa produced at the 4,000-liter scale in US children and adolescents with Pompe disease: ADVANCE, a phase IV, open-label, prospective study
Hahn SH, Kronn D, Leslie ND, et al.
Genetics in medicine : official journal of the American College of Medical Genetics, 2018
Psychometric analysis of the pediatric quality of life inventory 3.0 neuromuscular module administered to patients with duchenne muscular dystrophy: A rasch analysis
Landfeldt E, Mayhew A, Straub V, et al.
Muscle & Nerve, 2018
Duchenne and Becker muscular dystrophy in adolescents: current perspectives
Andrews JG, Andrews JG, Wahl RA
Adolescent health, medicine and therapeutics, 2018, 9, p 53
Developing treatment guidelines for myasthenia gravis
Sanders DB, Wolfe GI, Narayanaswami P
Annals of the New York Academy of Sciences, 2018, 1412, 1, p 95
Enhancing human aspects of care with young people with muscular dystrophy: Results from a participatory qualitative study with clinicians
Setchell J, Thille P, Abrams T, et al.
Child: care, health and development, 2018, 44, 2, p 269
Energy expenditure, body composition, and prevalence of metabolic disorders in patients with Duchenne muscular dystrophy
Saure C, Caminiti C, Weglinski J, et al.
Diabetes & metabolic syndrome, 2018, 12, 2, p 81
Growing patients with Duchenne muscular dystrophy: longitudinal changes in their dentofacial morphology and orofacial functional capacities
Egli F, Botteron S, Morel C, et al.
European journal of orthodontics, 2018, 40, 2, p 140
Clinical Characteristics of Juvenile Myasthenia Gravis in Southern China
Huang X, Li Y, Feng H, et al.
Frontiers in neurology, 2018, 9
Clinical features and evolution of juvenile myasthenia gravis in a French cohort
Barraud C, Desguerre I, Barnerias C, et al.
Muscle & Nerve, 2018, 57, 4, p 603
1H NMRS of carnosine combined with 31P NMRS to better characterize skeletal muscle pH dysregulation in Duchenne muscular dystrophy
Reyngoudt H, Turk S, Carlier PG
NMR in biomedicine, 2018, 31, 1
The clinical use of mechanical insufflation-exsufflation in children with neuromuscular disorders in Europe
Hov B, Andersen T, Hovland V, et al.
Paediatr Respir Rev., 2018, 27, p 69
Perioperative management of gastrostomy tube placement in Duchenne muscular dystrophy adolescent and young adult patients: A role for a perioperative surgical home
Boivin A, Antonelli R, Sethna NF
Paediatric anaesthesia, 2018, 28, 2, p 127
Du bon usage de l'ALPHA 300 et autres relaxateurs de pression
Schanen-Bergot MO, Gilabert S, Devaux C
Repères, Savoir & Comprendre, 2018, 6 p
Cardiovascular and cerebrovascular comorbidities of juvenile dermatomyositis in US children: an analysis of the National Inpatient Sample
Silverberg JI, Kwa L, Kwa MC, et al.
Rheumatology (Oxford, England), 2018, 57, 4, p 694
